They found that the CAR T cells targeting C1QBP reduced tumor vascularization and extended the overall survival of mice bearing gliomas, thus providing proof-of-principle evidence that C1QBP-CAR T cells can recognize and eliminate not only glioma cells but also tumor endothelial cells. Here, C1QBP is linked to central nervous system cancer.